Arbutus Biopharma Corp Stock Analysis
| ABUS Stock | USD 3.45 0.08 2.37% |
Arbutus Biopharma Corp is undervalued with Real Value of 4.27 and Hype Value of 3.45. The main objective of Arbutus Biopharma stock analysis is to determine its intrinsic value, which is an estimate of what Arbutus Biopharma Corp is worth, separate from its market price. There are two main types of Arbutus Biopharma's stock analysis: fundamental analysis and technical analysis.
The Arbutus Biopharma stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Arbutus Biopharma is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Arbutus Stock trading window is adjusted to America/New York timezone.
Arbutus |
Arbutus Stock Analysis Notes
About 22.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.43. Arbutus Biopharma Corp had not issued any dividends in recent years. The entity had 1:5 split on the 4th of November 2010. Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus infection, SARS-CoV-2, and other coronaviruses in the United States. Arbutus Biopharma Corporation is headquartered in Warminster, Pennsylvania. Arbutus Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 85 people. For more info on Arbutus Biopharma Corp please contact William Collier at 267 469 0914 or go to https://www.arbutusbio.com.Arbutus Biopharma Corp Investment Alerts
| The company reported the previous year's revenue of 18.14 M. Net Loss for the year was (72.85 M) with loss before overhead, payroll, taxes, and interest of (56.05 M). | |
| Arbutus Biopharma Corp currently holds about 150.2 M in cash with (85.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.0. | |
| Arbutus Biopharma has a frail financial position based on the latest SEC disclosures | |
| Roughly 55.0% of the company shares are held by institutions such as insurance companies |
Arbutus Biopharma Corp Upcoming and Recent Events
| 7th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 7th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Arbutus Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 653.75 M.Technical Drivers
As of the 1st of March, Arbutus Biopharma shows the mean deviation of 2.05, and Risk Adjusted Performance of 0.0163. Arbutus Biopharma Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Arbutus Biopharma Corp coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Arbutus Biopharma Corp is priced correctly, providing market reflects its regular price of 3.45 per share. Given that Arbutus Biopharma has jensen alpha of 0.0411, we suggest you to validate Arbutus Biopharma Corp's prevailing market performance to make sure the company can sustain itself at a future point.Arbutus Biopharma Corp Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Arbutus Biopharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Arbutus Biopharma Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Arbutus Biopharma Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Arbutus Biopharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Arbutus Biopharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Arbutus Biopharma insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Arbutus Biopharma Outstanding Bonds
Arbutus Biopharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Arbutus Biopharma Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Arbutus bonds can be classified according to their maturity, which is the date when Arbutus Biopharma Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Arbutus Biopharma Predictive Daily Indicators
Arbutus Biopharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Arbutus Biopharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Arbutus Biopharma Forecast Models
Arbutus Biopharma's time-series forecasting models are one of many Arbutus Biopharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Arbutus Biopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Arbutus Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Arbutus Biopharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Arbutus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Arbutus Biopharma. By using and applying Arbutus Stock analysis, traders can create a robust methodology for identifying Arbutus entry and exit points for their positions.
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus infection, SARS-CoV-2, and other coronaviruses in the United States. Arbutus Biopharma Corporation is headquartered in Warminster, Pennsylvania. Arbutus Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 85 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Arbutus Biopharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
Additional Tools for Arbutus Stock Analysis
When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.